Percorten-V (Desoxycorticosterone Pivalate) Injectable Suspension
This item requires prescription approval.
Prescription medications are currently limited to CA residents. More states coming soon!!
- Product Description
- Safety Information
- Side Effects
- Additional Information
Percorten-V contains Deoxycorticosterone Pivalate which is used as a hormone-replacement therapy for dogs with inadequate levels of stress hormones in their body (Addison's disease)
- The first FDA-approved treatment for canine Addison’s disease
Consult with your veterinarian for proper dosage and course of treatment.
Do not use in pregnant dogs or in dogs suffering from congestive heart failure, severe renal disease, or edema.
Some patients are more sensitive to the actions of Percorten-V and may exhibit side effects in an exaggerated degree. Some patients may show signs of hypothermia or hypokalemia. The dosage of Percorten-V should be reduced in these patients. Concomitant use of Percorten-V with potassium-sparing diuretics, such as spironolactone, may counter the effect of Percorten-V because deoxycorticosterone pivalate and potassium-sparing diuretics exhibit opposing mechanisms of action.
Food and Drug Interactions
Concomitant use of Percorten-V with potassium-sparing diuretics, such as spironolactone, may counter the effect of Percorten-V because deoxycorticosterone pivalate and potassium-sparing diuretics exhibit opposing mechanisms of action.
Keep this and all drugs out of reach of children.
Possible Side Effects
Percorten-V may cause severe side effects if dosage is too high or prolonged. The most common adverse reactions reported were depression/lethargy, vomiting, anorexia, polydipsia, and polyuria. Some of these effects may resolve with adjustments in dose or interval of Percorten-V or concomitant glucocorticoid administration.
Contact your veterinarian if you believe your pet is experiencing side effects.
Store at controlled room temperature with excursions between 59-86F permitted. Protect from light . Protect from freezing.